Example: Heart Attack

Search clinical trials for: Anastrozole

Total 224 results

NCT02188745

Recruiting

ER Reactivation Therapy for Breast Cancer

Conditions: Metastatic Breast Cancer
NCT01272037

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Synchronous Bilateral Breast Carcinoma
NCT00310180

Active, not recruiting

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Conditions: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7
NCT04711252

Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.

Conditions: ER-Positive HER2-Negative Breast Cancer
NCT04272801

Recruiting

Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer

Conditions: Breast Cancer Female
NCT04556773

Recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
NCT02057133

Active, not recruiting

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Conditions: Breast Neoplasms
NCT04075604

Active, not recruiting

A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Conditions: Breast Cancer, Cancer
NCT04436744

Recruiting

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Conditions: Early Breast Cancer
NCT02947685

Active, not recruiting

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

Conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer
NCT02763566

Active, not recruiting

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

Conditions: Breast Cancer
NCT02246621

Active, not recruiting

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Conditions: Breast Cancer
NCT03099174

Recruiting

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.

Conditions: Neoplasms, Breast Neoplasms
NCT00629616

Completed

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Conditions: Breast Cancer
NCT04059484

Recruiting

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Conditions: Breast Cancer Metastatic
NCT04719273

Recruiting

Onapristone and Anastrozole in Refractory Estrogen and Progesterone Positive Endometrial Cancer

Conditions: Refractory Endometrial Adenocarcinoma, Refractory Endometrial Carcinoma, Refractory Endometrial Clear Cell Adenocarcinoma, Refractory Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Mixed Cell Adenocarcinoma, Refractory Endometrial Serous Adenocarcinoma, Refractory Endometrial Undifferentiated Carcinoma
NCT03839823

Recruiting

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Conditions: Breast Cancer
NCT03966898

Active, not recruiting

A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Conditions: Advanced Breast Cancer
NCT03481998

Active, not recruiting

A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Conditions: Advanced Breast Cancer
NCT04906395

Not yet recruiting

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

Conditions: Breast Cancer
NCT03822468

Active, not recruiting

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Conditions: Breast Cancer
NCT02278120

Active, not recruiting

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Conditions: Advanced Metastatic Breast Cancer
NCT04886531

Not yet recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers

Conditions: Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer
NCT02942355

Recruiting

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Conditions: Female Breast Carcinoma
NCT00256217

Completed

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Conditions: DCIS